| Followers | 1131 |
| Posts | 32847 |
| Boards Moderated | 3 |
| Alias Born | 01/11/2016 |
Thursday, April 02, 2020 6:13:09 PM
Yes you right, just confirmed with a good friend that knows this stuff
$LGNDZ is ALSO a DIVIDEND VEHICLE!!!! It s not only a warrant!! its a VGR"!!!!!!!!! HUGE VALUE!!!!!!!!!!!!!!!$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
$LGNDZ is ALSO a DIVIDEND VEHICLE!!!! It s not only a warrant!! its a VGR"!!!!!!!!! HUGE VALUE!!!!!!!!!!!!!!!$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Recent LGND News
- Ligand to Participate in June Investor Conferences • GlobeNewswire Inc. • 05/27/2026 08:01:00 PM
- Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates • GlobeNewswire Inc. • 05/12/2026 08:18:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 11:03:45 AM
- Ligand Reports First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/07/2026 11:00:00 AM
- Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement • GlobeNewswire Inc. • 05/06/2026 12:01:00 PM
- Ligand to Participate in May Investor Conferences • GlobeNewswire Inc. • 05/05/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 12:20:10 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/01/2026 08:16:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:41:14 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation • PR Newswire (US) • 04/27/2026 07:06:00 PM
- Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator • GlobeNewswire Inc. • 04/27/2026 11:00:00 AM
- Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator • GlobeNewswire Inc. • 04/27/2026 11:00:00 AM
- Ligand to Report First Quarter 2026 Financial Results on May 7, 2026 • GlobeNewswire Inc. • 04/22/2026 11:00:00 AM
- Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS • GlobeNewswire Inc. • 04/14/2026 11:00:00 AM
- Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team • GlobeNewswire Inc. • 03/26/2026 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/23/2026 08:04:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2026 08:42:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 11:51:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 11:49:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2026 09:17:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 02:04:25 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 09:44:24 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 09:39:12 PM
- Ligand to Participate in March Investor Conferences • GlobeNewswire Inc. • 03/04/2026 12:00:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 02/27/2026 10:23:30 PM
